US Broker Ratings

Soleno Therapeutics (SLNO) Stock Analysis: Unveiling a Potential 164% Upside in the Biotech Arena

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a compelling prospect of a 164.22% upside potential, as indicated by the average analyst target price. Positioned within the healthcare..

Chemed Corp (CHE) Stock Analysis: Exploring a 24.34% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Chemed Corporation (NYSE: CHE) presents a compelling opportunity. Operating primarily in the United States, Chemed delivers hospice and palliative care..

Axsome Therapeutics (AXSM) Stock Analysis: Navigating a 13% Upside Potential in the Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a key player in the biotechnology sector, is making waves with its innovative approach to treating central nervous system (CNS) disorders. With a market cap..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unpacking the 32% Revenue Growth and Investor Ratings

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly within the medical devices industry, as it continues to redefine organ transplant therapies. With a market capitalization..

Qiagen N.V. (QGEN) Stock Analysis: Navigating the Diagnostics Giant’s Growth Amid Market Challenges

As investors seek promising opportunities in the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents a compelling case with its robust market presence and innovative product offerings. Headquartered in Venlo, the..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 100.75% Potential Upside in Biotech Investment

Summit Therapeutics Inc. (NASDAQ: SMMT) is making waves in the biotechnology sector with its innovative approach to medicinal therapies. With a market capitalization of $12.28 billion, this Miami-based biopharmaceutical company..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Growth with a 2.42% Potential Upside

Becton, Dickinson and Company (NYSE: BDX) represents a cornerstone in the healthcare sector, consistently proving its mettle in the competitive landscape of medical instruments and supplies. With a robust market..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 19% Upside with Strong Buy Ratings

For investors with an eye on the burgeoning field of oncology, BeOne Medicines Ltd. (ONC) presents a compelling opportunity. Operating out of Switzerland, this biotech heavyweight is making waves in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and Promising Genetic Medicine Pipeline

Krystal Biotech, Inc. (NASDAQ: KRYS) stands at the forefront of the biotechnology sector with its innovative approach to genetic medicine. Headquartered in Pittsburgh, Pennsylvania, the company is making significant strides..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 43.77% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is carving out a prominent niche in the biotechnology sector with its focus on innovative treatments for B-cell mediated diseases. As of today, the company’s..

West Pharmaceutical Services (WST) Stock Analysis: A 46% Upside Potential That Investors Can’t Ignore

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector, holds a prominent position in the medical instruments and supplies industry. With a market capitalization of $17.03..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking a 184% Potential Upside for Investors

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biopharmaceutical sector, holds significant promise for investors seeking opportunities in the rapidly evolving field of radiopharmaceuticals. With a strong focus..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Healthcare Giant with a 2.43% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO), a key player in the healthcare sector, stands at the intersection of innovation and tradition in the medical instruments and supplies industry. Known for..

IDEXX Laboratories, Inc. (IDXX): Investor Outlook with 10.40% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within diagnostics and research, is capturing attention with its robust market presence and growth potential. With a..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 56% Potential Upside with Strong Analyst Support

Doximity, Inc. (NYSE: DOCS) stands poised in the healthcare information services sector, presenting an intriguing investment opportunity, particularly for those eyeing substantial potential upside. With a market capitalization of $7.65..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, with a significant footprint in the medical distribution industry. As of its latest financial data, the..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 37.58% Potential Upside in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, specifically within the medical device industry. With a market capitalization of $5.17 billion, this San Francisco-based company is..

Charles River Laboratories (CRL): Investor Outlook Amidst Volatility and Strategic Alliances

Charles River Laboratories International, Inc. (NYSE: CRL) commands attention in the healthcare sector, specifically within diagnostics and research. With a market cap of $10.81 billion, this Massachusetts-headquartered company has established..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring an 18.54% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a noteworthy player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $3.24..

Stryker Corporation (SYK) Stock Analysis: Exploring a 20% Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, specifically within the medical devices industry, commands a significant market presence. With a market capitalization of $135.78 billion, Stryker..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds